{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:12:39Z","timestamp":1790885559671,"version":"4.1.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T00:00:00Z","timestamp":1565308800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T00:00:00Z","timestamp":1565308800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Dolcas Biotech LLC"},{"name":"Arjuna Natural LLC"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13104-019-4540-5","type":"journal-article","created":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T10:03:10Z","timestamp":1565344990000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Effect of curcumin supplementation on serum expression of select cytokines and chemokines in a female rat model of nonalcoholic steatohepatitis"],"prefix":"10.1186","volume":"12","author":[{"given":"Matthew B.","family":"Pickich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark W.","family":"Hargrove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Niles","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James C.","family":"Healy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelique N.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6762-086X","authenticated-orcid":false,"given":"Jeffrey S.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,9]]},"reference":[{"issue":"8","key":"4540_CR1","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","volume":"65","author":"E Buzzetti","year":"2016","unstructured":"Buzzetti E, Pinzani M, Tsochatzis EA. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). Metabolism. 2016;65(8):1038\u201348.","journal-title":"Metabolism"},{"issue":"2","key":"4540_CR2","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1093\/qjmed\/hcp158","volume":"103","author":"JK Dowman","year":"2009","unstructured":"Dowman JK, Tomlinson J, Newsome P. Pathogenesis of non-alcoholic fatty liver disease. QJM Int J Med. 2009;103(2):71\u201383.","journal-title":"QJM Int J Med"},{"issue":"2","key":"4540_CR3","first-page":"141","volume":"14","author":"JS Jurenka","year":"2009","unstructured":"Jurenka JS. Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research. Altern Med Rev. 2009;14(2):141\u201353.","journal-title":"Altern Med Rev"},{"issue":"2","key":"4540_CR4","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1080\/13813450802033958","volume":"114","author":"L Pari","year":"2008","unstructured":"Pari L, Tewas D, Eckel J. Role of curcumin in health and disease. Arch Physiol Biochem. 2008;114(2):127\u201349.","journal-title":"Arch Physiol Biochem"},{"issue":"7","key":"4540_CR5","doi-asserted-by":"publisher","first-page":"969","DOI":"10.2174\/1381612822666161010115235","volume":"23","author":"N Amel Zabihi","year":"2017","unstructured":"Amel Zabihi N, Pirro M, Johnston PT, Sahebkar A. Is there a role for curcumin supplementation in the treatment of non-alcoholic fatty liver disease? The data suggest yes. Curr Pharm Des. 2017;23(7):969\u201382.","journal-title":"Curr Pharm Des"},{"issue":"1","key":"4540_CR6","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/biof.1057","volume":"39","author":"L Vera-Ramirez","year":"2013","unstructured":"Vera-Ramirez L, P\u00e9rez-Lopez P, Varela-Lopez A, Ramirez-Tortosa M, Battino M, Quiles JL. Curcumin and liver disease. BioFactors. 2013;39(1):88\u2013100.","journal-title":"BioFactors"},{"issue":"6","key":"4540_CR7","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/j.jhep.2004.08.010","volume":"41","author":"IA Leclercq","year":"2004","unstructured":"Leclercq IA, Farrell GC, Sempoux C, dela Pena A, Horsmans Y. Curcumin inhibits NF-kappaB activation and reduces the severity of experimental steatohepatitis in mice. J Hepatol. 2004;41(6):926\u201334.","journal-title":"J Hepatol"},{"issue":"1","key":"4540_CR8","doi-asserted-by":"publisher","first-page":"6513","DOI":"10.1038\/s41598-017-06872-y","volume":"7","author":"HY Lee","year":"2017","unstructured":"Lee HY, Kim SW, Lee GH, Choi MK, Chung HW, Lee YC, Kim HR, Kwon HJ, Chae HJ. Curcumin and Curcuma longa L. extract ameliorate lipid accumulation through the regulation of the endoplasmic reticulum redox and ER stress. Sci Rep. 2017;7(1):6513.","journal-title":"Sci Rep"},{"issue":"2","key":"4540_CR9","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1089\/jmf.2007.555","volume":"11","author":"SJ Wu","year":"2008","unstructured":"Wu SJ, Lin YH, Chu CC, Tsai YH, Chao JC. Curcumin or saikosaponin a improves hepatic antioxidant capacity and protects against CCl4-induced liver injury in rats. J Med Food. 2008;11(2):224\u20139.","journal-title":"J Med Food"},{"issue":"9","key":"4540_CR10","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1002\/ptr.5659","volume":"30","author":"S Rahmani","year":"2016","unstructured":"Rahmani S, Asgary S, Askari G, Keshvari M, Hatamipour M, Feizi A, Sahebkar A. Treatment of non-alcoholic fatty liver disease with curcumin: a randomized placebo-controlled trial. Phytother Res. 2016;30(9):1540\u20138.","journal-title":"Phytother Res"},{"issue":"2","key":"4540_CR11","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1124\/mol.107.039818","volume":"73","author":"Y Fu","year":"2008","unstructured":"Fu Y, Zheng S, Lin J, Ryerse J, Chen A. Curcumin protects the rat liver from CCl4-caused injury and fibrogenesis by attenuating oxidative stress and suppressing inflammation. Mol Pharmacol. 2008;73(2):399\u2013409.","journal-title":"Mol Pharmacol"},{"issue":"4","key":"4540_CR12","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1111\/j.1472-8206.2008.00611.x","volume":"22","author":"K Reyes-Gordillo","year":"2008","unstructured":"Reyes-Gordillo K, Segovia J, Shibayama M, Tsutsumi V, Vergara P, Moreno MG, Muriel P. Curcumin prevents and reverses cirrhosis induced by bile duct obstruction or CCl4 in rats: role of TGF-beta modulation and oxidative stress. Fundam Clin Pharmacol. 2008;22(4):417\u201327.","journal-title":"Fundam Clin Pharmacol"},{"issue":"14","key":"4540_CR13","doi-asserted-by":"publisher","first-page":"e13789","DOI":"10.14814\/phy2.13789","volume":"6","author":"RP Cunningham","year":"2018","unstructured":"Cunningham RP, Moore MP, Moore AN, Healy JC, Roberts MD, Rector RS, Martin JS. Curcumin supplementation mitigates NASH development and progression in female Wistar rats. Physiol Rep. 2018;6(14):e13789.","journal-title":"Physiol Rep"},{"key":"4540_CR14","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/1471-230X-14-89","volume":"14","author":"TK Chheda","year":"2014","unstructured":"Chheda TK, Shivakumar P, Sadasivan SK, Chanderasekharan H, Moolemath Y, Oommen AM, Madanahalli JR, Marikunte VV. Fast food diet with CCl4 micro-dose induced hepatic-fibrosis\u2014a novel animal model. BMC Gastroenterol. 2014;14:89.","journal-title":"BMC Gastroenterol"},{"key":"4540_CR15","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1146\/annurev.immunol.21.120601.141142","volume":"21","author":"TA Wynn","year":"2003","unstructured":"Wynn TA. IL-13 effector functions. Annu Rev Immunol. 2003;21:425\u201356.","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"4540_CR16","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s10875-006-9066-7","volume":"27","author":"GC Jagetia","year":"2007","unstructured":"Jagetia GC, Aggarwal BB. \u201cSpicing up\u201d of the immune system by curcumin. J Clin Immunol. 2007;27(1):19\u201335.","journal-title":"J Clin Immunol"},{"issue":"2","key":"4540_CR17","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1097\/00024382-200302000-00011","volume":"19","author":"JP Gaddipati","year":"2003","unstructured":"Gaddipati JP, Sundar SV, Calemine J, Seth P, Sidhu GS, Maheshwari RK. Differential regulation of cytokines and transcription factors in liver by curcumin following hemorrhage\/resuscitation. Shock. 2003;19(2):150\u20136.","journal-title":"Shock"},{"issue":"6","key":"4540_CR18","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.coi.2003.09.004","volume":"15","author":"A Yoshimura","year":"2003","unstructured":"Yoshimura A, Mori H, Ohishi M, Aki D, Hanada T. Negative regulation of cytokine signaling influences inflammation. Curr Opin Immunol. 2003;15(6):704\u20138.","journal-title":"Curr Opin Immunol"},{"issue":"20","key":"4540_CR19","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1056\/NEJM200011163432007","volume":"343","author":"H Tilg","year":"2000","unstructured":"Tilg H, Diehl AM. Cytokines in alcoholic and nonalcoholic steatohepatitis. N Engl J Med. 2000;343(20):1467\u201376.","journal-title":"N Engl J Med"},{"issue":"5","key":"4540_CR20","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1002\/hep.23894","volume":"52","author":"KR Karlmark","year":"2010","unstructured":"Karlmark KR, Zimmermann HW, Roderburg C, Gassler N, Wasmuth HE, Luedde T, Trautwein C, Tacke F. The fractalkine receptor CX(3)CR20 protects against liver fibrosis by controlling differentiation and survival of infiltrating hepatic monocytes. Hepatology. 2010;52(5):1769\u201382.","journal-title":"Hepatology"},{"issue":"5","key":"4540_CR21","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1159\/000354525","volume":"32","author":"J Chen","year":"2013","unstructured":"Chen J, Liao MY, Gao XL, Zhong Q, Tang TT, Yu X, Liao YH, Cheng X. IL-17A induces pro-inflammatory cytokines production in macrophages via MAPKinases, NF-kappaB and AP-1. Cell Physiol Biochem. 2013;32(5):1265\u201374.","journal-title":"Cell Physiol Biochem"},{"issue":"2","key":"4540_CR22","doi-asserted-by":"publisher","first-page":"e0149783","DOI":"10.1371\/journal.pone.0149783","volume":"11","author":"DA Giles","year":"2016","unstructured":"Giles DA, Moreno-Fernandez ME, Stankiewicz TE, Cappelletti M, Huppert SS, Iwakura Y, Dong C, Shanmukhappa SK, Divanovic S. Regulation of inflammation by IL-17A and IL-17F modulates non-alcoholic fatty liver disease pathogenesis. PLoS ONE. 2016;11(2):e0149783.","journal-title":"PLoS ONE"},{"issue":"3","key":"4540_CR23","doi-asserted-by":"publisher","first-page":"332","DOI":"10.2174\/138945011794815356","volume":"12","author":"H Zhou","year":"2011","unstructured":"Zhou H, Beevers CS, Huang S. The targets of curcumin. Curr Drug Targets. 2011;12(3):332\u201347.","journal-title":"Curr Drug Targets"},{"issue":"7","key":"4540_CR24","first-page":"675","volume":"3","author":"G Kirovski","year":"2010","unstructured":"Kirovski G, Gabele E, Dorn C, Moleda L, Niessen C, Weiss TS, Wobser H, Schacherer D, Buechler C, Wasmuth HE, et al. Hepatic steatosis causes induction of the chemokine RANTES in the absence of significant hepatic inflammation. Int J Clin Exp Pathol. 2010;3(7):675\u201380.","journal-title":"Int J Clin Exp Pathol"},{"issue":"7","key":"4540_CR25","first-page":"1858","volume":"119","author":"E Seki","year":"2009","unstructured":"Seki E, De Minicis S, Gwak G-Y, Kluwe J, Inokuchi S, Bursill CA, Llovet JM, Brenner DA, Schwabe RF. CCR25 and CCR25 promote hepatic fibrosis in mice. J Clin Investig. 2009;119(7):1858\u201370.","journal-title":"J Clin Investig"},{"issue":"2","key":"4540_CR26","first-page":"145","volume":"19","author":"RO Recknagel","year":"1967","unstructured":"Recknagel RO. Carbon tetrachloride hepatotoxicity. Pharmacol Rev. 1967;19(2):145\u2013208.","journal-title":"Pharmacol Rev"},{"issue":"11","key":"4540_CR27","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1046\/j.1440-1746.2003.03198.x","volume":"18","author":"R Kirsch","year":"2003","unstructured":"Kirsch R, Clarkson V, Shephard EG, Marais DA, Jaffer MA, Woodburne VE, Kirsch RE, Hall Pde L. Rodent nutritional model of non-alcoholic steatohepatitis: species, strain and sex difference studies. J Gastroenterol Hepatol. 2003;18(11):1272\u201382.","journal-title":"J Gastroenterol Hepatol"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-019-4540-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13104-019-4540-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-019-4540-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,7]],"date-time":"2020-08-07T23:15:59Z","timestamp":1596842159000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/s13104-019-4540-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,9]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["4540"],"URL":"https:\/\/doi.org\/10.1186\/s13104-019-4540-5","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,9]]},"assertion":[{"value":"17 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All experimental procedures were approved by Auburn University\u2019s Institutional Animal Care and Use Committee (IACUC, protocol #2016-2839, approval date 01 March 2016).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"496"}}